Pernetrexed second-line treatment in malignant pleural mesothelioma following platinum-based first-line

被引:2
|
作者
Sorensen, J. B.
Sundstrom, S.
Perell, K.
Thielsen, A.
机构
[1] Natl Univ Hosp, Finsen Ctr, Copenhagen, Denmark
[2] St Olav Hosp, Trondheim, Norway
关键词
D O I
10.1016/S0169-5002(07)70268-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
192
引用
收藏
页码:S46 / S47
页数:2
相关论文
共 50 条
  • [31] Antifolates as second-line treatment in patients with malignant mesothelioma (MM)
    Marino, Antonella
    Pinto, Carmine
    Piana, Edera
    Martoni, Andrea
    ANNALS OF ONCOLOGY, 2005, 16 : 25 - 25
  • [32] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    Die Innere Medizin, 2024, 65 (4) : 325 - 333
  • [33] Methotrexate: first-line or second-line immunomodulator?
    Fraser, AG
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2003, 15 (03) : 225 - 231
  • [34] First-line and second-line antiretroviral therapy
    Calmy, A
    Pascual, F
    Ford, N
    LANCET, 2004, 364 (9431): : 329 - 329
  • [35] Momelotinib as first-line or second-line treatment following ruxolitinib in patients with primary or secondary myelofibrosis
    Sudria, Axel
    Alcazer, Vincent
    BULLETIN DU CANCER, 2024, 111 (09) : 796 - 798
  • [36] The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
    Guntulu Ak
    Selma Metintas
    Muhittin Akarsu
    Muzaffer Metintas
    BMC Cancer, 15
  • [37] The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
    Ak, Guntulu
    Metintas, Selma
    Akarsu, Muhittin
    Metintas, Muzaffer
    BMC CANCER, 2015, 15
  • [38] Treatment of Primary Biliary Cholangitis First-Line and Second-Line Therapies
    Liu, Chung-Heng
    Bowlus, Christopher L.
    CLINICS IN LIVER DISEASE, 2022, 26 (04) : 705 - 726
  • [39] Raltitrexed-oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients
    Porta, C
    Zimatore, M
    Bonomi, L
    Imarisio, I
    Paglino, C
    Sartore-Bianchi, A
    Mutti, L
    LUNG CANCER, 2005, 48 (03) : 429 - 434
  • [40] A gentle therapy: Weekly epirubicin, as second-line treatment in elderly patients with malignant pleural mesothelioma (MPM).
    Bollina, Roberto
    Belloni, Paolo
    Pelliccione, Michela
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)